Metabolic Dysfunction-Associated Steatohepatitis (MASH) Clinical Trials
3 recruiting trials for Metabolic Dysfunction-Associated Steatohepatitis (MASH). Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 3NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or...
This study is open to adults who are at least 18 years old living with obesity and have: * a confirmed liver disease called non-alcoholic steatohepatitis (NASH)/metabolic...
Sponsor: Boehringer IngelheimEnrolling: 180020 locations
RECRUITINGPhase 1NCT06947304
Evaluation of Miricorilant on Liver Fat in Patients With MASLD
A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients with Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Sponsor: Corcept TherapeuticsEnrolling: 81 location
RECRUITINGPhase 4NCT06374875
Fibrosis Lessens After Metabolic Surgery
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), a major global public health concern, is commonly...
Sponsor: Ali AminianEnrolling: 12020 locations